摘要
随着基础医学、医疗设备、高新技术的进展和循证医学的广泛开展,血运重建技术已经取得了快速的进展。左主干病变可通过内科和外科手段实现心肌血运重建,缓解症状,改善预后和延长寿命。目前血运重建措施有经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)。但是对于更适当的治疗措施尚无定论。故本文就PCI和CABG在左主干病变患者的治疗效果做一综述。
With the progress of basic medicine, medical equipment, high and new technology and evidence- based medicine, the technology of revascularization has developed rapidly. For left main coronary artery disease, medication and surgery can achieve myocardial revascularization, relieve symptoms, improve prognosis and prolong life. At present, the measures coronary intervention and coronary artery bypass graft current treatment strategies of percutaneous coronary adopted to achieve revascularization are percutaneous surgery. In this review, our investigation describes intervention and coronary artery bypass graft surgery for left main coronary artery disease.
作者
覃雄海
蒋树林
康凯
QIN Xiong-hai, JIANG Shu-lin, KANG Kai(Department of Cardiovascular Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, Heilongjiang, Chin)
出处
《心脏杂志》
CAS
2018年第3期364-367,共4页
Chinese Heart Journal
关键词
经皮冠状动脉介入治疗
冠状动脉旁路移植术
左主干病变
血运重建
percutaneous coronary intervention
coronary artery bypass graft surgery
left main coronary artery disease
revascularization